Versus Systems Inc.
VS Nasdaq Services-Computer Processing & Data Preparation Financials FY2022βFY2025
What Versus Systems Inc. does
No business description yet.
- Legal name
- Versus Systems Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Apr 15, 2026
- Accession Β· CIK
- 0001213900-26-044110
0001701963
Revenue and margins
Versus Systems Inc. had $2.2M of revenue in fiscal 2025, up 3,710.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Versus Systems Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 86.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably Versus Systems Inc. can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $1.2M | $4.7M | $3.1M | $0.5M |
| Interest coverage | β | β | β255.0x | β |
| Current ratio | 0.4x | 15.1x | 134.4x | 10.2x |
| Quick ratio | 0.4x | 15.1x | 134.4x | 10.2x |
| Total assets | $8.1M | $4.9M | $3.5M | $2.1M |
| Total liabilities | $3.3M | $0.3M | $0.0M | $0.1M |
| Shareholders' equity | $11.1M | $11.9M | $11.4M | $10.2M |
| Net debt (β = net cash) | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | β | β | β | β |
| Cash from operations is positive | β | β | β | β |
| Return on assets rose | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β |
| Debt fell relative to assets | β | β | β | β |
| Current ratio rose | β | β | β | β |
| Share count didn't rise | β | β | β | β |
| Gross margin rose | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β |
| F-score | β / 3 | 4 / 7 | 2 / 8 | 3 / 8 |
| Accruals ratio | β165.3% | β61.0% | 22.1% | 9.3% |
| Altman Z'' | β67.84 | β60.33 | 325.58 | β151.39 |
4 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $1.1M | $0.3M | $0.1M | $2.2M |
| Gross profit | $0.5M | $0.2M | $0.0M | $2.2M |
| Research and development | $2.4M | $1.1M | $0.2M | $0.0M |
| Operating income | β$22.7M | β$10.9M | β$4.5M | β$2.2M |
| Interest expense | β | β | $0.0M | β |
| Pretax income | β$22.5M | β$10.5M | β$4.6M | β$2.1M |
| Income tax | β | β | $0.0M | $0.0M |
| Net income | β$22.5M | β$9.5M | β$4.0M | β$1.8M |
| Diluted EPS | β$192.89 | β$10.44 | β$1.54 | β$0.37 |
| Diluted shares | β | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||
| Cash from operations | β$9.2M | β$5.6M | β$5.0M | β$2.1M |
| Capital expenditure | $0.0M | β | β | β |
| Free cash flow | β$9.2M | β | β | β |
| Depreciation and amortization | β | $0.0M | $0.0M | β |
| Stock-based compensation | $1.6M | β$1.5M | $0.2M | $0.4M |
| Balance sheet | ||||
| Cash and short-term investments | $1.2M | $4.7M | $3.1M | $0.5M |
| Deposits | $0.1M | β | β | β |
| Current assets | $1.5M | $4.9M | $3.5M | $1.5M |
| Current liabilities | $3.3M | $0.3M | $0.0M | $0.1M |
| Property and equipment, net | $0.1M | $0.0M | β | β |
| Intangible assets | $6.4M | β | β | $0.6M |
| Total assets | $8.1M | $4.9M | $3.5M | $2.1M |
| Total liabilities | $3.3M | $0.3M | $0.0M | $0.1M |
| Shareholders' equity | $11.1M | $11.9M | $11.4M | $10.2M |
| Margins | ||||
| Gross margin | 44.4% | 62.0% | 29.7% | 99.2% |
| Operating margin | β2,044.7% | β4,001.6% | β7,921.8% | β99.0% |
| EBITDA margin | β | β3,992.9% | β7,918.8% | β |
| Net margin | β2,026.8% | β3,512.9% | β7,054.6% | β82.1% |
| FCF margin | β829.2% | β | β | β |
| Returns | ||||
| Return on capital employed | β478.9% | β238.2% | β129.3% | β112.7% |
| Return on equity | β201.8% | β82.6% | β34.6% | β16.6% |
| Return on assets | β278.9% | β147.3% | β96.1% | β64.0% |
| Return on tangible equity | β473.8% | β79.8% | β35.4% | β18.7% |
| Growth | ||||
| Revenue growth | β | β75.5% | β78.9% | 3,710.5% |
| Share count change | β | β | 188.0% | 86.5% |
| Financial health | ||||
| Interest coverage | β | β | β255.0x | β |
| Current ratio | 0.4x | 15.1x | 134.4x | 10.2x |
| Quick ratio | 0.4x | 15.1x | 134.4x | 10.2x |
| Capital allocation | ||||
| Capex / revenue | 3.6% | β | β | β |
| Stock comp / revenue | 141.4% | β535.5% | 280.8% | 19.7% |
| Quality scores | ||||
| Piotroski F-score | β | 4.0 | 2.0 | 3.0 |
| Altman Z'' | β67.8 | β60.3 | 325.6 | β151.4 |
| Accruals ratio | β165.3% | β61.0% | 22.1% | 9.3% |
Source: SEC EDGAR XBRL filings (CIK 0001701963). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.